A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Hoffmann-La Roche
National Cancer Institute (NCI)
City of Hope Medical Center
Bristol-Myers Squibb
Stanford University
Duke University
Duke University
Duke University
Duke University